Aastrom Biosciences Added to Russell Microcap Index
June 30, 2014 08:30 ET
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., June 30, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
Aastrom Announces Initiation of Commercial Sales of Bone Marrow by Marrow Donation, LLC
June 24, 2014 08:45 ET
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., June 24, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
Aastrom Announces Strategic Plan for Recently Acquired Cell Therapy and Regenerative Medicine Business
June 16, 2014 06:00 ET
|
Aastrom Biosciences, Inc.
Manufacturing of MACI in Denmark to be discontinued
Sales of MACI in Europe, representing 1% of revenues in 2014, temporarily ceased
U.S. action plan implemented to optimize R&D,...
Aastrom Announces Investor Conference Call and Webcast June 16, 2014 at 8:30 AM EDT
June 15, 2014 18:00 ET
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., June 15, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
Aastrom Announces Appointment of Gerard Michel as Chief Financial Officer and Vice President, Corporate Development
June 04, 2014 08:45 ET
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., June 4, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
Aastrom Completes Acquisition of Sanofi's Cell Therapy and Regenerative Medicine Business
June 02, 2014 08:45 ET
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., June 2, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
Aastrom Biosciences Reports First-Quarter 2014 Financial Results
May 15, 2014 16:05 ET
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., May 15, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe,...
Aastrom Biosciences to Host First Quarter 2014 Investor Call on May 15, 2014
May 09, 2014 16:05 ET
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., May 9, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe...
Aastrom to Hold Annual Meeting of Shareholders on May 7, 2014
May 02, 2014 16:05 ET
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., May 2, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe,...
Aastrom Announces Definitive Agreement to Acquire Sanofi's Cell Therapy and Regenerative Medicine Business
April 21, 2014 08:30 ET
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., April 21, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe,...